432 related articles for article (PubMed ID: 33767160)
1. Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids.
Lepore Signorile M; Grossi V; Di Franco S; Forte G; Disciglio V; Fasano C; Sanese P; De Marco K; Susca FC; Mangiapane LR; Nicotra A; Di Carlo G; Dituri F; Giannelli G; Ingravallo G; Canettieri G; Stassi G; Simone C
Cell Death Dis; 2021 Mar; 12(4):316. PubMed ID: 33767160
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling p38α nuclear and cytoplasmic functions and identification of two p38α phosphorylation sites on β-catenin: implications for the Wnt signaling pathway in CRC models.
Lepore Signorile M; Fasano C; Forte G; De Marco K; Sanese P; Disciglio V; Di Nicola E; Pantaleo A; Simone C; Grossi V
Cell Biosci; 2023 Dec; 13(1):223. PubMed ID: 38041178
[TBL] [Abstract][Full Text] [Related]
3. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
4. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
5. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation.
Cho YH; Ro EJ; Yoon JS; Mizutani T; Kang DW; Park JC; Il Kim T; Clevers H; Choi KY
Nat Commun; 2020 Oct; 11(1):5321. PubMed ID: 33087710
[TBL] [Abstract][Full Text] [Related]
6. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
[TBL] [Abstract][Full Text] [Related]
7. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
[TBL] [Abstract][Full Text] [Related]
8. Small molecule-induced simultaneous destabilization of β-catenin and RAS is an effective molecular strategy to suppress stemness of colorectal cancer cells.
Cho YH; Ro EJ; Yoon JS; Kwak DK; Cho J; Kang DW; Lee HY; Choi KY
Cell Commun Signal; 2020 Mar; 18(1):38. PubMed ID: 32143715
[TBL] [Abstract][Full Text] [Related]
9. Differentiated cancer cell-originated lactate promotes the self-renewal of cancer stem cells in patient-derived colorectal cancer organoids.
Zhao H; Yan C; Hu Y; Mu L; Liu S; Huang K; Li Q; Li X; Tao D; Qin J
Cancer Lett; 2020 Nov; 493():236-244. PubMed ID: 32898601
[TBL] [Abstract][Full Text] [Related]
10. Canonical Wnt Pathway Is Involved in Chemoresistance and Cell Cycle Arrest Induction in Colon Cancer Cell Line Spheroids.
Moreno-Londoño AP; Castañeda-Patlán MC; Sarabia-Sánchez MA; Macías-Silva M; Robles-Flores M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982333
[TBL] [Abstract][Full Text] [Related]
11. c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer.
Lepore Signorile M; Grossi V; Fasano C; Forte G; Disciglio V; Sanese P; De Marco K; La Rocca F; Armentano R; Valentini AM; Giannelli G; Simone C
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230763
[TBL] [Abstract][Full Text] [Related]
12. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
13. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
[TBL] [Abstract][Full Text] [Related]
14. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity.
Wang L; Deng K; Gong L; Zhou L; Sayed S; Li H; Sun Q; Su Z; Wang Z; Liu S; Zhu H; Song J; Lu D
Pharmacol Res; 2020 Sep; 159():104955. PubMed ID: 32485279
[TBL] [Abstract][Full Text] [Related]
15. Gamma-mangostin isolated from garcinia mangostana suppresses colon carcinogenesis and stemness by downregulating the GSK3β/β-catenin/CDK6 cancer stem pathway.
Wu AT; Yeh YC; Huang YJ; Mokgautsi N; Lawal B; Huang TH
Phytomedicine; 2022 Jan; 95():153797. PubMed ID: 34802869
[TBL] [Abstract][Full Text] [Related]
16. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
17. p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.
Grossi V; Peserico A; Tezil T; Simone C
World J Gastroenterol; 2014 Aug; 20(29):9744-58. PubMed ID: 25110412
[TBL] [Abstract][Full Text] [Related]
18. LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer.
Nie X; Liu H; Ye W; Wei X; Fan L; Ma H; Li L; Xue W; Qi W; Wang YD; Chen WD
J Cell Mol Med; 2022 Feb; 26(4):1095-1112. PubMed ID: 34997691
[TBL] [Abstract][Full Text] [Related]
19. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
[TBL] [Abstract][Full Text] [Related]
20. BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer.
Moor AE; Anderle P; Cantù C; Rodriguez P; Wiedemann N; Baruthio F; Deka J; André S; Valenta T; Moor MB; Győrffy B; Barras D; Delorenzi M; Basler K; Aguet M
EBioMedicine; 2015 Dec; 2(12):1932-43. PubMed ID: 26844272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
